Paysign develops and operates prepaid card programs and payment platforms used for healthcare patient-affordability support, corporate incentives, and fund disbursements. Its technology handles card issuance, load and spend controls, compliance, and program reporting for sponsors such as pharmaceutical companies, employers, and government or benefit programs. The company is known for specialized healthcare card solutions that help patients access medications and treatments under manufacturer assistance and similar programs.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 18.6 | — | 2.6 | 390.2% |
| Q2 2025 | 19.1 | — | 1.4 | 161.9% |
| Q3 2025 | 21.6 | — | 2.2 | 27.7% |
| Q4 2025 | 22.8 | — | 1.4 | 27.2% |
| Q1 2026 | 28 | 50.8% | 5.4 | 110.3% |
| Q2 2026 | 28.3 | 48.1% | 6.8 | 386.9% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Cullinan Therapeutics, Inc. (CGEM), Monte Rosa Therapeutics, Inc. (GLUE), Daily Journal Corporation (DJCO), Strategy Inc (STRD), Liberty Capital Corporation (GLIBK), Sify Technologies Limited (SIFY)